Navigation Links
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2013 First Quarter Financial Results
Date:5/10/2013

.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor StatementThis press release contains "forward-looking statements", including statements relating to Lexicon's clinical development of LX4211, telotristat etiprate (LX1032) and LX1033, including characterizations of the results of and projected timing of clinical trials of such compounds, and the potential therapeutic and commercial potential of LX4211, telotristat etiprate (LX1032) and LX1033.  In addition, this press release also contains forward-looking statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information.  All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct clinical development of LX4211, telotristat etiprate (LX1032) and LX1033 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Information identifying such important fa
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Lexicon Advances LX4211 In Type 1 Diabetes Phase 2 Trial
2. Lexicon to Report First Quarter Financial Results on May 10, 2013
3. Lexicon To Present At The Needham Healthcare Conference
4. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2012 Fourth Quarter And Full Year Financial Results
5. Lexicon To Present At The BIO CEO & Investor Conference
6. Lexicon Pharmaceuticals To Present At The Piper Jaffray Annual Healthcare Conference
7. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2012 Third Quarter Results
8. Lexicon to Provide Third Quarter 2012 Financial Results
9. Lexicon Pharmaceuticals To Present At The Stifel Nicolaus 2012 Healthcare Conference
10. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
11. Lexicon Pharmaceuticals To Present At The Wedbush PacGrow 2012 Management Access Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful PSE ... meth offenders and make arrests. Data released by ... blocked the sale of more than ...
(Date:8/20/2014)... Md. , Aug. 20, 2014  The ... lauded the latest results achieved by the real-time, ... as the National Precursor Log Exchange (NPLEx), automatically ... officials track down methamphetamine offenders and make arrests. ... Michigan blocked the sale ...
(Date:8/20/2014)... 2014 Reportlinker.com announces that a ... its catalogue: Personal Accident and ... Opportunities to 2018 ... provides in depth market analysis, information and ... health insurance segment, including: - The French ...
Breaking Medicine Technology:Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Michigan's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 2Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 3Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 4Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 5Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 6Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 7Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 8Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 9Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 10Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 11Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 12Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 13Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 14Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 15Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 16Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 17Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 18Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 19Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 20Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 21Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 22Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 23
... Calif., March 15, 2011 XTIO2 INC ... -nominees with the XTI ANTI-GERM / ANTI-VOC / ... and XTI™  Nano-Facemask . It is the ... against germs transmitted via air and contact surfaces. The ...
... FRANCISCO, March 15, 2011 Motion Therapeutics, Inc. ... for balance and mobility disorders, today announced that researchers ... a NIH Recovery Act Grant to study the effects ... and mobility in people with MS. ...
Cached Medicine Technology:OSCAR® Nominees Receive (XTIO2 INC.) XTI 360™ Nano Coating Anti-Germ System 2OSCAR® Nominees Receive (XTIO2 INC.) XTI 360™ Nano Coating Anti-Germ System 3The Balance-Based Torso-Weighting® Treatment for Multiple Sclerosis Receives a NIH Recovery Act Grant 2
(Date:8/20/2014)... Tampa, FL (PRWEB) August 20, 2014 Locating ... for users of the Quotes Pros website. A new source ... adults price and review rates good for all 50 states ... now configured is one of the new methods available for ... different insurer packages that are supplied. The instant quotations that ...
(Date:8/20/2014)... in Australia examined patient and tumor characteristics for ... tumor cell growth) in an effort to increase ... , Author: Sarah Shen, M.B.B.S., ... colleagues. , Background: The tumor characteristic known ... been connected with prognosis and survival in melanoma ...
(Date:8/20/2014)... NY (PRWEB) August 20, 2014 Hundreds ... on behalf of women who were allegedly injured due ... forward in New Jersey’s Bergen County Superior Court, Bernstein ... issued on August 15, 2014, the Court has established ... for Mirena lawsuits that are part of the proceeding’s ...
(Date:8/20/2014)... Steven Reinberg HealthDay Reporter ... which cancer cells grow may help doctors diagnose and treat ... measure, investigators have found that the deadliest skin cancers occur ... with a long history of sun exposure. These lesions ... Rapid cell growth -- called "high mitotic rate" ...
(Date:8/20/2014)... Aug. 20, 2014 A common approach to treating ... did not improve survival chances for people who suddenly ... at the University of Pittsburgh School of Medicine. , ... One , suggest acute hemodialysis, an aggressive method that ... may not provide a definitive benefit to the patient. ...
Breaking Medicine News(10 mins):Health News:Term Life Insurance Price Database Now Helps Quote Prices for Adults in 50 States Online 2Health News:Patient, tumor characteristics for high-mitotic rate melanoma 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 3Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 4Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 2Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 3Health News:Pitt analysis questions use of acute hemodialysis treatment 2
... Family Research Council President Tony Perkins ... limits on federal funding of embryonic stem cell ... Amendment. (Logo: http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO )"Sadly, President Barack Obama ... embryonic stem cell research. In his statement today, ...
... Method helps doctors better distinguish cancer types, researcher says, ... technique that more accurately determines the stage of bladder ... a new study says. , U.S. researchers studied 70 ... about 95 percent accurate in identifying bladder cancer that ...
... Borrowing from the iconic I Love NY logo, Ogilvy New ... a new campaign logo for the American Red Cross of ... to recruit New Yorkers to become Red Cross Reserve volunteers.The ... Governor David Paterson -- is part of a multi-channel marketing ...
... Indoor Air Quality to Create Better HealthBOCA RATON, Fla., March ... Florida Department of Health has received many complaints from homeowners ... homes is causing serious health problems and damages. The ... drywall used in the construction of the homes. Residents ...
... The following statement may be attributed to Amy ... Research (CAMR): "For the past eight years, Americans of ... restrictive policy that put politics ahead of science and ... how we treat diseases. Today, thanks to the ...
... March 9 Genaera Corporation (Nasdaq: GENR ... 4350(b)(1)(B), that the audit report included in the Company,s ... fiscal year ended December 31, 2008 contained an unqualified ... KPMG LLP, which included a "going concern" explanatory paragraph. ...
Cached Medicine News:Health News:Technique Might Prevent Some Bladder Removals 2Health News:American Red Cross of Greater New York Launches New Effort to Recruit 10,000 Disaster Volunteers 2Health News:American Red Cross of Greater New York Launches New Effort to Recruit 10,000 Disaster Volunteers 3Health News:Your Home May Be Harming You: Environmental Protection Agency States Indoor Environments Are 5-20 Times More Polluted Than Outdoors 2Health News:Your Home May Be Harming You: Environmental Protection Agency States Indoor Environments Are 5-20 Times More Polluted Than Outdoors 3Health News:CAMR Applauds President Obama's Commitment to Embryonic Stem Cell Research 2Health News:Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph 2
... Endoscopic CycloPhotocoagulation (ECP) is a surgical ... endoscopy and visualized laser application. The ciliary ... by the surgeon, from the anterior or ... time. The target tissues are easily and ...
... German Craftsmanship have produced the ... world. Ocutek® now makes them ... of the coveted Meisterbrief certificate, ... are qualified to become Ocutek ...
... Centuries of German Craftsmanship ... instrumentation in the world. Ocutek® ... you! Only holders of the ... and eight-year apprenticeship, are qualified ...
... German Craftsmanship have produced the ... world. Ocutek® now makes them ... of the coveted Meisterbrief certificate, ... are qualified to become Ocutek ...
Medicine Products: